Portland Health wins Mundipharma account

Handling communications for the pain, oncology and asthma specialist

Portland Health, the recently launched healthcare arm of Portland Communications, has been appointed by Mundipharma International to handle its corporate communications.

The Cambridge, UK-based pharmaceutical company is structured as a network of independent associated companies, consisting of privately owned businesses and joint ventures. Together they have a focus on therapy areas including pain, oncology, rheumatoid arthritis and respiratory.

High on the Portland Health's agenda will be to raise the profile of the recently launched asthma drug Flutiform (fluticasone/formoterol).

In addition, the comms agency will also be tasked with driving more general awareness of Mundipharma, as it looks to expand across Europe, in terms of employees, potential clients and partnerships.

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...